FDC116115: A prospective study of sexual function in sexually active men treated for BPH
Latest Information Update: 22 Aug 2023
At a glance
- Drugs Dutasteride/tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 11 Jan 2020 Results of post hoc analysis assessing the impact of baseline characteristics on Mens Sexual Health Questionnaire (MSHQ) total scores and evaluating the clinical relevance of MSHQ changes and their association with spontaneously reported sexual adverse events in patients with benign prostatic hyperplasia published in the International Journal of Clinical Practice
- 13 Oct 2018 Results of a post-hoc analysis published in the International Journal of Clinical Practice.
- 16 Oct 2017 Primary endpoint of total MSHQ scores at month 12 has been met, according to results published in the BJU International.